38
Views
122
CrossRef citations to date
0
Altmetric
Mammalian Genetic Models with Minimal or Complex Phenotypes

Perinatal Lethality and Endothelial Cell Abnormalities in Several Vessel Compartments of Fibulin-1-Deficient Mice

, , , , , & show all
Pages 7025-7034 | Received 31 May 2001, Accepted 11 Jul 2001, Published online: 27 Mar 2023

REFERENCES

  • Argraves, W. S., H. Tran, W. H. Burgess, and K. Dickerson. 1990. Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure. J. Cell Biol. 111:3155–3164.
  • Aspberg, A., S. Adam, G. Kostka, R. Timpl, and D. Heinegard. 1999. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J. Biol. Chem. 274:20444–20449.
  • Aszódi, A., A. Pfeiffer, M. Wendel, L. Hiripi, and R. Fässler. 1998. Mouse models of extracellular matrix diseases. J. Mol. Med. 76:238–252.
  • Bader, B. L., H. Rayburn, D. Crowley, and R. O. Hynes. 1998. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all αV integrins. Cell 95:507–519.
  • Balbona, K., H. Tran, S. Godyna, K. C. Ingham, D. K. Strickland, and W. S. Argraves. 1992. Fibulin binds to itself and to the carboxyl-terminal heparin-binding region of fibronectin. J. Biol. Chem. 267:20120–20125.
  • Barth, J. L., K. M. Argraves, E. F. Roark, C. D. Little, and W. S. Argraves. 1998. Identification of chicken and C. elegans fibulin-1 homologs and characterization of the C. elegans fibulin-1 gene. Matrix Biol. 17:635–646.
  • Beck, L., and P. A. D'Amore. 1997. Vascular development: cellular and molecular regulation. FASEB J. 11:365–373.
  • Benjamin, L. E., I. Hemo, and E. Keshet. 1998. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591–1598.
  • Bloch, W., E. Forsberg, S. Lentini, C. Brakebusch, K. Martin, H. W. Krell, U. H. Weidle, K. Addicks, and R. Fässler. 1997. β1 integrin is essential for teratoma growth and angiogenesis. J. Cell Biol. 139:265–278.
  • Bouchey, D., W. S. Argraves, and C. D. Little. 1996. Fibulin-1, vitronectin and fibronectin expression during avian cardiac valve and septa development. Anat. Rec. 244:540–551.
  • Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, and A. Nagy. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435–439.
  • Carmeliet, P., and R. K. Jain. 2000. Angiogenesis in cancer and other diseases. Nature 407:249–257.
  • Cui, J., K. S. O'Shea, A. Purkayastha, T. L. Saunder, and D. Ginsburg. 1996. Fatal hemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 384:66–68.
  • Darland, D. C., and P. A. D'Amore. 1999. Blood vessel maturation: Vascular development comes of age. J. Clin. Investig. 103:157–158.
  • Davis, G. E., and C. W. Camarillo. 1996. An α2β1 integrin-dependent pinocytic mechanism involving intracellular vacuole formation and coalescence regulates capillary lumen and tube formation in three-dimensional collagen matrix. Exp. Cell Res. 224:39–51.
  • Fässler, R., and M. Meyer. 1995. Consequences of lack of β1 integrin gene expression in mice. Genes Dev. 9:1896–1908.
  • Fässler, R., E. Georges-Labouesse, and E. Hirsch. 1996. Genetic analysis of integrin function in mice. Curr. Opin. Cell Biol. 8:641–646.
  • Ferrara, N., K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hillan, and M. W. Moore. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439–442.
  • Folkman, J., and P. A. D'Amore. 1996. Blood vessel formation: what is its molecular basis?. Cell 87:1153–1155.
  • George, E. L., H. S. Baldwin, and R. O. Hynes. 1997. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of presursor cells. Blood 90:3073–3081.
  • Giltay, R., R. Timpl, and G. Kostka. 1999. Sequence, recombinant expression and tissue localization of two novel extracellular matrix proteins, fibulin-3 and fibulin-4. Matrix Biol. 18:469–480.
  • Hanahan, D.. 1997. Signaling vascular morphogenesis and maintenance. Science 277:48–50.
  • Hartner, A., H. Schöckelmann, F. Pröls, U. Müller, and R. B. Sterzel. 1999. α8 integrin in glomerular mesangial cells and in experimental glomerulonephritis. Kidney Int. 56:1468–1480.
  • Hodivala-Dilke, K. M., K. P. McHugh, D. A. Tsakiris, H. Rayburn, D. Crowley, M. Ullman-Culeré, F. P. Ross, B. S. Coller, S. Teitelbaum, and R. O. Hynes. 1999. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Investig. 103:229–238.
  • Huang, Z.-F., D. Higuchi, N. Lasky, and G. J. Broze. 1997. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 90:944–951.
  • Hungerford, J. E., G. K. Owens, W. S. Argraves, and C. D. Little. 1996. Development of aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev. Biol. 178:375–392.
  • Hynes, R. O.. 1996. Targeted mutations in cell adhesion genes: what have we learned from them?. Dev. Biol. 180:402–412.
  • Kluge, M., K. Mann, M. Dziadek, and R. Timpl. 1990. Characterization of a novel calcium-binding 90-kDa glycoprotein (BM-90) shared by basement membranes and serum. Eur. J. Biochem. 193:651–659.
  • Kreidberg, J. A., M. J. Donovan, S. L. Goldstein, H. Rennke, K. Shepherd, R. C. Jones, and R. Jaenisch. 1996. α3β1 integrin has a crucial role in kidney and lung organogenesis. Development 122:3537–3547.
  • Levéen, P., M. Pekny, S. Gebre-Medhin, B. Swolin, E. Larsson, and C. Betsholtz. 1994. Mice deficient for PDGF B show renal, cardiovascular and hematological abnormalities. Genes Dev. 8:1875–1887.
  • Li, D. Y., B. Brooke, E. C. Davis, R. P. Mecham, L. K. Sörensen, B. B. Boak, E. Eichwald, and M. T. Keating. 1998. Elastin is an essential determinant of arterial morphogenesis. Nature 393:276–280.
  • Lindahl, P., P. R. Johansson, P. Levéen, and C. Betsholtz. 1997. Pericyte loss and microaneurism formation in PDGF-B-deficient mice. Science 277:242–245.
  • Löhler, J., R. Timpl, and R. Jaenisch. 1984. Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell 38:597–606.
  • Miner, J. H., and C. Li. 2000. Defective glomerulogenesis in the absence of laminin α5 demonstrates a developmental role for the kidney glomerular basement membrane. Dev. Biol. 217:278–289.
  • Miosge, N., T. Sasaki, M. L. Chu, R. Herken, and R. Timpl. 1997. Ultrastructural localization of microfibrillar fibulin-1 and fibulin-2 during heart development indicates a switch in molecular associations. Cell. Mol. Life Sci. 54:606–613.
  • Miosge, N., T. Sasaki, and R. Timpl. 1999. Angiogenesis inhibitor endostatin is a distinct component of elatic fibers in vessel walls. FASEB J. 13:1743–1750.
  • Mundel, P., J. Reiser, and W. Kritz. 1997. Introduction of differentiation in cultured rat and human podocytes. J. Am. Soc. Nephrol. 8:697–705.
  • Pan, T.-C., T. Sasaki, R.-Z. Zhang, R. Fässler, R. Timpl, and M.-L. Chu. 1993. Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium-binding. J. Cell Biol. 123:1269–1277.
  • Pan, T.-C., G. Kostka, R.-Z. Zhang, R. Timpl, and M.-L. Chu. 1999. Complete exon-intron organization of the mouse fibulin-1 gene and its comparison with the human fibulin-1 gene. FEBS Lett. 444:38–42.
  • Pereira, L., K. Andrikopoulos, J. Tian, S. Y. Lee, D. R. Keene, R. Ono, D. P. Reinhardt, L. Y. Sakai, N. J. Biery, T. Bunton, H. C. Dietz, and F. Ramirez. 1997. Targetting the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat. Genet. 17:218–222.
  • Pfaff, M., T. Sasaki, K. Tangemann, M.-L. Chu, and R. Timpl. 1995. Integrin-binding and cell-adhesion studies of fibulins reveal a particular affinity for αIIbβ3. Exp. Cell Res. 219:87–92.
  • Ramirez, F.. 1996. Fibrillin mutations in Marfan syndrome and related phenotypes. Curr. Opin. Genet. Dev. 6:309–315.
  • Reinhardt, D. P., T. Sasaki, B. J. Dzamba, D. R. Keene, M.-L. Chu, W. Göhring, R. Timpl, and L. Y. Sakai. 1996. Fibrillin-1 and fibulin-2 interact and are colocalized in some tissues. J. Biol. Chem. 271:19489–19496.
  • Risau, W.. 1995. Differentiation of endothelium. FASEB J. 9:926–933.
  • Risau, W.. 1997. Mechanisms of angiogenesis. Nature 386:671–674.
  • Roark, E. F., D. R. Keene, C. C. Haudenschild, S. Godyna, C. D. Little, and W. S. Argraves. 1995. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J. Histochem. Cytochem. 43:401–411.
  • Rousseau, S., F. Houle, J. Landry, and J. Huot. 1997. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15:2169–2177.
  • Sasaki, T., G. Kostka, W. Göhring, H. Wiedemann, K. Mann, M.-L. Chu, and R. Timpl. 1995. Structural characterization of two variants of fibulin-1 that differ in nidogen affinity. J. Mol. Biol. 245:241–250.
  • Sasaki, T., H. Wiedemann, M. Matzner, M. L. Chu, and R. Timpl. 1996. Expression of fibulin-2 by fibroblasts and deposition with fibronectin into a fibrillar matrix. J. Cell Sci. 109:2895–2904.
  • Sasaki, T., N. Fukai, K. Mann, W. Göhring, B. R. Olsen, and R. Timpl. 1998. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17:4249–4256.
  • Sasaki, T., W. Göhring, N. Miosge, W. R. Abrams, J. Rosenbloom, and R. Timpl. 1999. Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins. FEBS Lett. 460:280–284.
  • Schulze, B., K. Mann, R. Battistutta, H. Wiedemann, and R. Timpl. 1995. Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif. Eur. J. Biochem. 231:551–556.
  • Sims, J. R., S. Karp, and D. E. Ingber. 1992. Altering the cellular mechanical force balance results in integrated changes in cell, cytoskeletal and nuclear shape. J. Cell Sci. 103:1215–1222.
  • Soriano, P.. 1994. Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes Dev. 8:1888–1898.
  • Suh, T. T., K. Holmbäck, N. J. Jensen, C. C. Daugherty, K. Small, D. I. Simon, S. S. Potter, and J. L. Degen. 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9:2020–2033.
  • Sun, W. Y., D. P. Witte, J. L. Degen, M. C. Colbert, M. C. Burkart, K. Holmbäck, Q. Xiao, T. H. Bugge, and S. F. J. Degen. 1998. Prothrombin deficiency results in embryonic and neonatal lethality in mice. Proc. Natl. Acad. Sci. USA 95:7597–7602.
  • Talts, J. F., K. Mann, Y. Yamada, and R. Timpl. 1998. Structural analysis and proteolytic processing of recombinant G domain of mouse laminin α2 chain. FEBS Lett. 426:71–76.
  • Thurston, G., C. Suri, K. Smith, J. McClain, T. N. Sato, G. D. Yancopoulos, and D. M. McDonald. 1999. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511–2514.
  • Tran, H., A. Tanaka, S. V. Litvinovich, L. V. Medved, C. C. Haudenschild, and W. S. Argraves. 1995. The interaction of fibulin-1 with fibrinogen. A potential role in hemostasis and thrombosis. J. Biol. Chem. 270:19458–19464.
  • Xue, J., Q. Wu, L. A. Westfield, E. A. Tuley, D. Lu, Q. Zhang, K. Shim, X. Zheng, and J. E. Sadler. 1998. Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice. Proc. Natl. Acad. Sci. USA 95:7603–7607.
  • Yang, J. T., H. Rayburn, and R. O. Hynes. 1993. Embryonic mesodermal defects in α5 integrin-deficient mice. Development 119:1093–1105.
  • Zhang, H. Y., M. Kluge, R. Timpl, M. L. Chu, and P. Ekblom. 1993. The extracellular matrix glycoproteins BM-90 and tenascin are expressed in the mesenchyme at sites of endothelial-mesenchymal conversion in the embryonic mouse heart. Differentiation 52:211–220.
  • Zhang, H.-Y., M.-L. Chu, T.-C. Pan, T. Sasaki, R. Timpl, and P. Ekblom. 1995. Extracellular matrix protein fibulin-2 is expressed in the embryonic endocardial cushion tissue and is a prominent component of valves in adult heart. Dev. Biol. 167:18–26.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.